|
1.
|
Bennett A and White J: Improving care and
quality of life for patients with lung cancer. Nursing Stand.
28:50–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Gutierrez-Fernandez A, Fueyo A, Folgueras
AR, et al: Matrix metalloproteinase-8 functions as a metastasis
suppressor through modulation of tumor cell adhesion and invasion.
Cancer Res. 68:2755–2763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Sugahara KN, Hirata T, Tanaka T, et al:
Chondroitin sulfate E fragments enhance CD44 cleavage and
CD44-dependent motility in tumor cells. Cancer Res. 68:7191–7199.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ghaffar H, Sahin F, Sanchez-Cepedes M, et
al: LKB1 protein expression in the evolution of glandular neoplasia
of the lung. Clin Cancer Res. 9:2998–3003. 2003.PubMed/NCBI
|
|
5.
|
Jimenez AI, Fernandez P, Dominguez O,
Dopazo A and Sanchez-Cespedes M: Growth and molecular profile of
lung cancer cells expressing ectopic LKB1: down-regulation of the
phosphatidylinositol 3′-phosphate kinase/PTEN pathway. Cancer Res.
63:1382–1388. 2003.PubMed/NCBI
|
|
6.
|
Marcus AI and Zhou W: LKB1 regulated
pathways in lung cancer invasion and metastasis. J Thorac oncol.
5:1883–1886. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Liang X, Nan KJ and Xu QZ: Effect of small
interfering RNA-induced LKB1 gene silencing on the biological
behavior of lung carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao.
27:1303–1306. 2007.(In Chinese).
|
|
8.
|
Liang X, Nan KJ, Li CL, Yao Y, Tian T and
Wang SH: Effect of transfection of LKB1 on biological behavior of
human lung adenocarcinoma cells. Xi Bao Yu Fen Zi Mian Yi Xue Za
Zhi. 24:1140–1142. 2008.(In Chinese).
|
|
9.
|
Liang X, Nan KJ, Li ZL and Xu QZ:
Overexpression of the LKB1 gene inhibits lung carcinoma cell
proliferation partly through degradation of c-myc protein. Oncol
Rep. 21:925–931. 2009.PubMed/NCBI
|
|
10.
|
Ylikorkala A, Rossi DJ, Korsisaari N, et
al: Vascular abnormalities and deregulation of VEGF in
Lkb1-deficient mice. Science. 293:1323–1326. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Brugarolas J and Kaelin WG Jr:
Dysregulation of HIF and VEGF is a unifying feature of the familial
hamartoma syndromes. Cancer Cell. 6:7–10. 2004. View Article : Google Scholar
|
|
12.
|
Nakasaki T, Wada H, Shigemori C, et al:
Expression of tissue factor and vascular endothelial growth factor
is associated with angiogenesis in colorectal cancer. Am J Hematol.
69:247–254. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Zhang J, Ding J, Zhang X, Shao X and Hao
Z: Regulation of vascular endothelial growth factor (VEGF)
production and angiogenesis by tissue factor (TF) in SGC-7901
gastric cancer cells. Cancer Biol Ther. 4:769–772. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Koomagi R and Volm M: Tissue-factor
expression in human non-small-cell lung carcinoma measured by
immunohistochemistry: correlation between tissue factor and
angiogenesis. Int J Cancer. 79:19–22. 1998. View Article : Google Scholar
|
|
15.
|
Li ZL, Xu WJ, Tian PX, et al: Recombinant
adenovirus-mediated RNA silencing of tissue factor expression in
human islet: an in vitro study. Nan Fang Yi Ke Da Xue Xue Bao.
27:1299–1302. 2007.(In Chinese).
|
|
16.
|
Ji H, Ramsey MR, Hayes DN, et al: LKB1
modulates lung cancer differentiation and metastasis. Nature.
448:807–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Xu C, Gui Q, Chen W, et al: Small
interference RNA targeting tissue factor inhibits human lung
adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res.
30:632011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Minamiya Y, Matsuzaki I, Sageshima M, et
al: Expression of tissue factor mRNA and invasion of blood vessels
by tumor cells in non-small cell lung cancer. Surg Today. 34:1–5.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mohammadi B, Haghpanah V and Larijani B: A
stochastic model of tumor angiogenesis. Comput Biol Med.
38:1007–1011. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Vokes E, Herbst R and Sandler A:
Angiogenesis inhibition in the treatment of lung cancer. Clin Adv
Hematol Oncol. 4:1–10. 2006.PubMed/NCBI
|
|
21.
|
Wang S, Liu H, Ren L, Pan Y and Zhang Y:
Inhibiting colorectal carcinoma growth and metastasis by blocking
the expression of VEGF using RNA interference. Neoplasia.
10:399–407. 2008.PubMed/NCBI
|
|
22.
|
Rickles FR, Shoji M and Abe K: The role of
the hemostatic system in tumor growth, metastasis, and
angiogenesis: tissue factor is a bifunctional molecule capable of
inducing both fibrin deposition and angiogenesis in cancer. Int J
Hematol. 73:145–150. 2001. View Article : Google Scholar
|
|
23.
|
Regina S, Rollin J, Blechet C, Iochmann S,
Reverdiau P and Gruel Y: Tissue factor expression in non-small cell
lung cancer: relationship with vascular endothelial growth factor
expression, microvascular density, and K-ras mutation. J Thorac
Oncol. 3:689–697. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Poon RT, Lau CP, Ho JW, Yu WC, Fan ST and
Wong J: Tissue factor expression correlates with tumor angiogenesis
and invasiveness in human hepatocellular carcinoma. Clin Cancer
Res. 9:5339–5345. 2003.PubMed/NCBI
|
|
25.
|
Regina S, Valentin JB, Lachot S, Lemarie
E, Rollin J and Gruel Y: Increased tissue factor expression is
associated with reduced survival in non-small cell lung cancer and
with mutations of TP53 and PTEN. Clin Chem. 55:1834–1842. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Han S and Roman J: COX-2 inhibitors
suppress integrin alpha5 expression in human lung carcinoma cells
through activation of Erk: involvement of Sp1 and AP-1 sites. Int J
Cancer. 116:536–546. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Zhang J, Jia Z, Li Q, et al: Elevated
expression of vascular endothelial growth factor correlates with
increased angiogenesis and decreased progression-free survival
among patients with low-grade neuroendocrine tumors. Cancer.
109:1478–1486. 2007. View Article : Google Scholar
|
|
28.
|
Lutzner N, De-Castro AJ and Rosl F: Gene
expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y
and FOXO transcription factors. PLoS One. 7:e325902012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Shi Q, Le X, Abbruzzese JL, et al:
Constitutive Sp1 activity is essential for differential
constitutive expression of vascular endothelial growth factor in
human pancreatic adenocarcinoma. Cancer Res. 61:4143–4154.
2001.PubMed/NCBI
|
|
30.
|
Ishibashi H, Nakagawa K, Onimaru M, et al:
Sp1 decoy transfected to carcinoma cells suppresses the expression
of vascular endothelial growth factor, transforming growth factor
beta1, and tissue factor and also cell growth and invasion
activities. Cancer Res. 60:6531–6536. 2000.
|
